Table 2.

Clinical trials quality assessment according to Jadad score.

Author, Year	Was the research described as randomized?	Was the Approach of randomization appropriate?	Was the research described as blinding?	Was the approach of blinding appropriate?	Was there a presentation of withdrawal and dropouts?	Was there a presentation of the inclusion/exclusion criteria?	Was the approach used to assess adverse effects described?	Was the approach of statistical analysis described?	Total
Iranzo et al., 2014 [28]	1	1	0	0	1	1	0	1	5
Yadav et al., 2015 [29]	1	1	0.5	1	0	1	0	1	5.5
Agnihotri et al., 2016 [30]	1	1	0	0	1	1	0	1	5
Artchoudane et al., 2018 [31]	1	1	0.5	−1	1	1	0	1	4.5
Yudhawati and RasjidHs., 2019 [32]	1	−1	0	0	0	1	0	1	2
Pushpa and Sharma., 2018 [33]	1	−1	0	0	0	1	0	1	2
Yüce and Tascı., 2020 [34]	1	1	0.5	1	1	1	0	1	6.5
Dhargave et al., 2021 [35]	1	1	0	0	1	1	0	1	5
Gunjiganvi et al., 2021 [36]	1	1	0	0	1	1	1	1	6
Yadav et al., 2021 [37]	1	1	0	0	0	1	0	1	2